Albert Font
0000-0003-3908-1111
1 paper found
Refreshing results…
Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1)
Missing publications? Search for publications with a matching author name.